Drugs / Glycerin Suppository
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT07226739 | Jun 2026 → Jan 2031 expected | autism spectrum disorder 1, bowel dysfunction | Emory University | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT06048614 Comparator | Jan 2024 → Aug 2027 expected | meconium ileus | KK Women's and Children's Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycerin Suppository | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06048614 ↗ |